Bavarian Nordic AS

BV3

Company Profile

  • Business description

    Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

  • Contact

    Philip Heymans Alle 3
    Hellerup2900
    DNK

    T: +45 33268383

    E: [email protected]

    https://www.bavarian-nordic.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    1,653

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,013.708.20-0.10%
CAC 407,285.8644.11-0.60%
DAX 4021,205.86105.16-0.49%
Dow JONES (US)38,170.41971.82-2.48%
FTSE 1008,275.660.060.00%
HKSE21,558.95163.810.77%
NASDAQ15,870.90415.55-2.55%
Nikkei 22534,224.3355.59-0.16%
NZX 50 Index11,836.69282.30-2.33%
S&P 5005,158.20124.50-2.36%
S&P/ASX 2007,816.702.40-0.03%
SSE Composite Index3,306.7815.350.47%

Market Movers